Terumo (OTCMKTS:TRUMY) Stock Passes Below 50-Day Moving Average – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $13.68 and traded as low as $13.6250. Terumo shares last traded at $13.7255, with a volume of 94,402 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Terumo to a “hold” rating in a research note on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Terumo Trading Up 2.0%

The stock has a market cap of $20.25 billion, a P/E ratio of 22.50 and a beta of 0.67. The stock’s 50-day moving average is $13.68 and its two-hundred day moving average is $13.69. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.97.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.11. Terumo had a net margin of 12.09% and a return on equity of 9.17%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.84 billion. Equities research analysts anticipate that Terumo Corp. will post 0.7 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.